Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Motoji Kogushi"'
Autor:
Motoji Kogushi, Kenichi Chiba, Takashi Musha, Shuichi Suzuki, Akiharu Kajiwara, Ieharu Hishinuma, Tetsuya Kawahara, Tsutomu Kawata, Toshiyuki Matsuoka, Kimiyo Murakami, Akifumi Kimura, Hiroko Kuramochi
Publikováno v:
European Journal of Pharmacology. 666:158-164
Thrombin is a powerful agonist for a variety of cellular responses including platelet aggregation and vascular smooth muscle cell (SMC) proliferation. These actions are mediated by a thrombin receptor known as protease-activated receptor-1 (PAR-1). R
Autor:
Shinji Yoshitake, Toshie Yamada, Takashi Musha, Mamoru Yanagimachi, Motoji Kogushi, Hiroko Kobayashi, Takanori Kawamura, Osamu Ito, Hiroshi Tanaka, Masashi Ito, Masahiro Takada, Isao Saito, Fusayo Yoshida
Publikováno v:
Circulation Research. 82:980-987
Abstract —An antibody was raised in rabbits against SFFLRNPSEDTFEQF peptide, which is an NH 2 -terminal peptide of the thrombin-cleaved rat thrombin receptor. In vitro, the antibody inhibited rat smooth muscle cell proliferation but had no effect o
Autor:
Teiji Kimura, Hiroko Kobayashi, Shinji Yoshitake, Takao Saeki, Issei Ohtsuka, Toshie Yamada, Hiroshi Tanaka, Motoji Kogushi, Isao Saito, Hironobu Hiyoshi, Masahiro Takada, Mamoru Yanagimachi
Publikováno v:
Atherosclerosis. 124:203-210
E5324, n-butyl-N'-[2-[3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxy]-6- methylphenyl]urea, a novel and potent inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), was evaluated for its anti-atherosclerotic and lipid-lowering effects in Watanabe h
Autor:
Hiroko Kobayashi, Teiji Kimura, Isao Saito, Motoji Kogushi, Issei Ohtsuka, Toshie Yamada, Hiroshi Tanaka
Publikováno v:
Japanese Journal of Pharmacology. 68:191-199
The in vitro potencies of a novel inhibitor of acyl-CoA :cholesterol acyltransferase (ACAT), E5324 (n-butyl-N'-[2-[3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxy] -6-methylphenyl]urea), were studied. E5324 was found to be a potent ACAT inhibitor in mic
Autor:
Motoji Kogushi, Masahiro Takada, Hiroko Kobayashi, Hiroshi Tanaka, Toshie Yamada, Osamu Ito, Shinji Yoshitake, Isao Saito
Publikováno v:
Journal of Receptors and Signal Transduction. 15:103-115
Baby hamster kidney (BHK) cells transfected with an expression vector for the human thrombin receptor, and then treated with basic fibroblast growth factor, were found to express specific and saturable binding sites for biotinylated thrombin receptor
Autor:
Kenji Hayashi, Teiji Kimura, Hiroko Kobayashi, Takao Saeki, Hiroshi Tanaka, Toshie Yamada, Tohru Fujimori, Issei Ohtsuka, Motoji Kogushi, Hironobu Hiyoshi, Isao Saito
Publikováno v:
Atherosclerosis. 107:187-201
E5324, n-butyl-N′-[2-[3-(5-ethyl-4-phenyl-lH-imidazol-1-yl)propoxy]-6-methylphenyl]urea, a novel and orally absorbable acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, was evaluated for its antiatherosclerotic and antihyperlipidemic effects i
Publikováno v:
Japanese Journal of Pharmacology. 61:7-12
E5510, 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid, is a new anti-platelet-aggregation agent under development. We examined the inhibitory efficacy of E5510 on PDGF-release from washed human platelets. E5510 concentration-dependently inhibited
Autor:
Shuichi Suzuki, Akiharu Kajiwara, Motoji Kogushi, Hironobu Hiyoshi, Kimiyo Murakami, Ieharu Hishinuma, Tsutomu Kawata, Tetsuya Kawahara, Shinki Kawaguchi, Hiroko Kuramochi, Toshiyuki Matsuoka
Publikováno v:
European journal of pharmacology. 657(1-3)
Thrombin is a powerful agonist for platelets, the action of which is mediated by the thrombin receptor protease-activated receptor-1 (PAR-1). Recently, we discovered that E5555 (1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1
Publikováno v:
Thrombosis and haemostasis. 102(1)
SummaryE5555 is a potent protease-activated receptor (PAR-1) antagonist targeting the G-coupled receptor and modulating thrombinplatelet-endothelial interactions. The drug is currently being tested in phase II trials in patients with coronary artery
Autor:
Ohtsuka I, Takao Saeki, Teiji Kimura, Hayashi K, I. Saitou, Tohru Fujimori, Yamada T, Yasutaka Takase, Motoji Kogushi, Hiroshi Tanaka
Publikováno v:
Journal of medicinal chemistry. 36(11)
We have discovered N-butyl-N'-[2-(dimethylamino)-6-[3-(4-phenyl-1H- imidazol-1-yl)propoxy]phenyl]urea (4), a novel, potent, and systemically bioavailable inhibitor of ACAT (acylCoA:cholesterol O-acyltransferase). The structure-activity relationships